{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T16:09:06Z","timestamp":1714579746177},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,12,15]]},"DOI":"10.2169\/internalmedicine.3318-19","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T22:03:04Z","timestamp":1566943384000},"page":"3563-3568","source":"Crossref","is-referenced-by-count":2,"title":["Glucose-responsive Insulinoma with Insulin Hypersecretion Suppressed by Metformin"],"prefix":"10.2169","volume":"58","author":[{"given":"Kunihisa","family":"Hamano","sequence":"first","affiliation":[{"name":"Division of Nephrology and Diabetology, Narita Memorial Hospital (Meiyokai Medical Corporation), Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Akita","sequence":"additional","affiliation":[{"name":"Department of Thyroidology and Diabetes, Japanese Red Cross Gifu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Diabetology, Narita Memorial Hospital (Meiyokai Medical Corporation), Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Suwa","sequence":"additional","affiliation":[{"name":"Department of Immunity and Endocrinology Internal Medicine, Gifu University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Takeda","sequence":"additional","affiliation":[{"name":"Koseikai Takeda Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Dodo","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Diabetology, Narita Memorial Hospital (Meiyokai Medical Corporation), Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Service FJ, McMahon MM, O&apos;Brien PC, Ballard DJ. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66: 711-719, 1991."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 94: 1069-1073, 2009.","DOI":"10.1210\/jc.2008-2031"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Power L. A glucose-responsive insulinoma. JAMA 207: 893-896, 1969.","DOI":"10.1001\/jama.207.5.893"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rayfield EJ, Pulini M, Golub A, Rubenstein AH, Horwitz DL. Nonautonomous functions of a pancreatic in- sulinoma. J Clin Endocrinol Metab 43: 1307-1311, 1976.","DOI":"10.1210\/jcem-43-6-1307"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Conner H, Scarpello JHB. An insulinoma presenting with reactive hypoglycamia. Postgrad Med J 55: 735-738, 1979.","DOI":"10.1136\/pgmj.55.648.735"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dinyer GR, Oldenburger D. Clinically unsuspected insulinoma. Minn Med 63: 241-242, 1980.","DOI":"10.1093\/jaoac\/63.2.241a"},{"key":"7","unstructured":"7. Sjoberg RJ, Kidd GS. Case report: a glucose responsive insulinoma-implication for the diagnosis of insulin secreting tumors. Am J Med Sci 304: 164-167, 1992."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Iida K, Ohara T, Hino Y, Nobuhara M, Ishida J, Chihara K. Glucose-responsive insulinoma in a patient with postprandial hypoglycemia in the morning. Intern Med 49: 2123-2127, 2010.","DOI":"10.2169\/internalmedicine.49.3854"},{"key":"9","unstructured":"9. Shah MH, Goldner WS, Halfdanarson TR, et al. NCCn guidelines insights: neuroendocrine and adrenal tumors, Version 2.2018. J Natl Compr Canc Netw 16: 693-702, 2018."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tamburrano G, Leonetti F, Sbraccia P, Giaccari A, Locuratolo N, Lala A. Increased insulin sensitivity in patients with idiopathic responsive hypoglycemia. J Clin Endocrinol Metab 69: 885-890, 1989.","DOI":"10.1210\/jcem-69-4-885"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hofeldt FD. Responsive hypoglycemia. Endocrinol Metab Clin North Am 18: 185-201, 1989.","DOI":"10.1016\/S0889-8529(18)30396-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Skelin M, Rupnik M, Cencic A. Pancreatic beta cell lines and their applications in diabetes mellitus research. ALTEX 27: 105-113, 2010.","DOI":"10.14573\/altex.2010.2.105"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Matschinsky FM. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45: 223-241, 1996.","DOI":"10.2337\/diabetes.45.2.223"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kojima I, Medina J, Nakagawa Y. Role of the glucose-sensing receptor in insulin secretion. Diabetes Obes Metab 19: 54-62, 2017.","DOI":"10.1111\/dom.13013"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Malaisse WJ. Insulin release: the receptor hypothesis. Diabetologia 57: 1287-1290, 2014.","DOI":"10.1007\/s00125-014-3221-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Medina J, Nakagawa Y, Nagasawa M, et al. Positive allosteric modulation of the calcium-sensing receptor by physiological concentrations of glucose. J Biol Chem 291: 23126-23135, 2016.","DOI":"10.1074\/jbc.M116.729863"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Seino Y, Yamamoto T, Inoue K, et al. Abnormal facilitative glucose transporter gene expression in human islet cell tumors. J Clin Endocrinol Metab 76: 75-78, 1993.","DOI":"10.1210\/jc.76.1.75"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Boden G, Murer E, Mozzoli M. Glucose transporter proteins in human insulinoma. Ann Intern Med 121: 109-112, 1994.","DOI":"10.7326\/0003-4819-121-2-199407150-00005"},{"key":"19","unstructured":"19. Tan MH, Alquraini H, Mizokami-Stout K, MacEachern M. Metformin: from research to clinical practice. Endocrinol Metab Clin North Am 45: 819-843, 2016."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wilcock C, Bailey CJ. Reconsideration of inhibitory effect of metformin on intestinal glucose absorption. J Pharm Pharmacol 43: 120-121, 1991.","DOI":"10.1111\/j.2042-7158.1991.tb06645.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348: 607-614, 2000.","DOI":"10.1042\/bj3480607"},{"key":"22","unstructured":"22. Leclerc I, Woltersdorf WW, da Silva Xavier G, et al. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 286: E1023-E1031, 2004."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Gelin L, Li J, Corbin KL, Jahan I, Nunemaker CS. Metformin inhibits mouse islet insulin secretion and alters intracellular calcium in a concentration-dependent and duration-dependent manner near the circulating range. J Diabetes Res 22, 2018.","DOI":"10.1155\/2018\/9163052"},{"key":"24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pdi.1655","volume":"29","author":"P George","year":"2012","unstructured":"24. George P, McCrimmon R. Diazoxide. Practical Diabetes 29: 36-37, 2012.","journal-title":"Practical Diabetes","ISSN":"http:\/\/id.crossref.org\/issn\/2047-2897","issn-type":"print"},{"key":"25","unstructured":"25. Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia 60: 1586-1593, 2017."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/24\/58_3318-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T16:15:50Z","timestamp":1664208950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/24\/58_3318-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,15]]},"references-count":25,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3318-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,15]]}}}